项目编号 PRJCA023207
项目标题 PARP inhibitors enhance anti-tumor immune responses by triggering pyroptosis via TNF-caspase8-GSDMD/E axis
涉及领域 Medical
数据类型 Transcriptome or Gene expression
Raw sequence reads
物种名称 Mus musculus
Homo sapiens
描述信息 Besides the well-established synthetic lethality, PARP inhibition can also trigger immune responses that contribute to tumor suppression. Yet the pharmacological effect remains incompletely understood. Using TCR-sequencing and histological analyses of mouse ID8 tumors and clinical specimens from a prospective study (NCT04507841), we found that PARP inhibitors triggered tumor immunogenic cell death (ICD), which resulted in the transition into a "hot" tumor immune microenvironment (TIME) and enhanced tumor-targeting immune responses. The ICD induced by PARP inhibitors has characteristics of pyroptosis such as classic morphological changes and GSDMD/E cleavage. This GSDMD/E cleavage was closely associated with the increased caspase 8 activity that was located downstream of the TNF signaling pathway but not FAS/FASL and TRAIL. PARP inhibition-activated NF-κB contributed to the secretion of TNF-α, resulting in the activation of caspase 8 without inhibition by c-FLIP. Blocking pyroptosis with the depletion of GSDMD and GSDME facilitated tumor growth and impaired immune response in a syngeneic mouse model. Hence, our data revealed a novel mechanism by which PARP inhibitors inflame TIME and drive tumor-targeting immune response, with potential applications in developing effective combinational therapies for tumors.
样品范围 Multispecies
发布日期 2024-10-26
出版信息
PubMed ID 文章标题 杂志名称 Doi 发表年份
39366751 PARP inhibitors enhance antitumor immune responses by triggering pyroptosis via TNF–caspase 8–GSDMD/E axis in ovarian cancer Journal for Immunotherapy of Cancer 10.1136/jitc-2024-009032 2024
项目资金来源
机构 项目类型 授权项目ID 授权项目名称
Ministry of Science and Technology of the People's Republic of China (MOST) National Key Technologies R&D Program 2022YFC2704200
Ministry of Science and Technology of the People's Republic of China (MOST) National Key Technologies R&D Program 2022YFC2704205
National Natural Science Foundation of China (NSFC) 81902933
National Natural Science Foundation of China (NSFC) 82372928
National Natural Science Foundation of China (NSFC) 82072889
提交者 Qinglei Gao (qingleigao@hotmail.com)
提交单位 Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology
提交日期 2024-01-25

项目包含数据信息

资源名称 描述
BioSample (24)  show -
GSA (1) -
CRA014711 TCRseq data of ovarian cancer after niraparib treatment